CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Circulating MiRNA indentificationother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04746586
NCT04746586N/ACompleted

Identification and Characterization of Circulating microRNAs as Diagnostic Biomarkers in Adolescent Idiopathic Scoliosis

Istituto Ortopedico Rizzoli·observational·Posted Feb 10, 2021·Updated May 22, 2026

In Brief

An observational study evaluating Circulating MiRNA indentification for Adolescent Idiopathic Scoliosis. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The aim of the present study is to evaluate the expression of a large panel of microRNAs, already known and validated in other ortopedic pathologies and bone metabolism, in the plasma of Adolescent Idiopathic Scoliosis (AIS) patients. The deregulated microRNAs identified will be then validated and computational analyzes will determine their potential involvement in the metabolism of bone and/or cartilage tissue in order to correlate the results obtained with the clinical data of the AIS patients. The investigators aimed to develop a microRNAs panel to further validate in a larger population of AIS patients in order to produce a device for the diagnosis and prognosis of Molecular-based AIS.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedFeb 10, 2021
Enrollment StartJul 22, 2020
Primary CompletionAug 31, 2022
Study CompletionDec 21, 2025
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 5.4 years ago

Interventions

Circulating MiRNA indentificationother

Identification of circulating miRNA useful to discriminate between worsening and stable forms of AIS